Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/12/21 EDT
151.80quote price arrow down-0.88 (-0.58%)
Volume
116,388
Close
152.68UNCH (UNCH)
Volume
5,521,922
52 week range
46.13 - 189.26

...

Loading . . .
  • Open154.11
  • Day High158.91
  • Day Low151.15
  • Prev Close158.99
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low46.13
  • 52 Week Low Date05/27/20

Key Stats

  • Market Cap61.306B
  • Shares Out401.53M
  • 10 Day Average Volume13.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.48
  • YTD % Change46.15

KEY STATS

  • Open154.11
  • Day High158.91
  • Day Low151.15
  • Prev Close158.99
  • 52 Week High189.26
  • 52 Week High Date02/08/21
  • 52 Week Low46.13
  • 52 Week Low Date05/27/20
  • Market Cap61.306B
  • Shares Out401.53M
  • 10 Day Average Volume13.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.48
  • YTD % Change46.15

RATIOS/PROFITABILITY

  • EPS (TTM)1.25
  • P/E (TTM)121.73
  • Fwd P/E (NTM)6.26
  • EBITDA (MRQ)672.52M
  • ROE (MRQ)21.84%
  • Revenue (MRQ)2.732B
  • Gross Margin (MRQ)84.44%
  • Net Margin (MRQ)21.89%
  • Debt To Equity (MRQ)4.77%

EVENTS

  • Earnings Date08/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO1:3801:38
Triple-mutant Covid variant from India is now a potential global health risk

Profile

MORE
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
372.84UNCHUNCH
BNTX
BioNTech SE
186.13UNCHUNCH
SGEN
Seagen Inc
144.77UNCHUNCH
INCY
Incyte Corp
82.37UNCHUNCH
GMAB
Genmab A/S
36.33UNCHUNCH